John B. Replogle
John B. Replogle's purchase track record
How the stock did after each of John B. Replogle's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/11/2025 | CROX | $224K | +11.3% | +32.4% | +8.1% |
| 8/8/2025 | CROX | $250K | +4.8% | +14.1% | +8.5% |
| 5/21/2025 | GROV | $50K | +23.7% | +14.4% | +13.7% |
| 10/30/2024 | CROX | $252K | -3.9% | -11.5% | -4.2% |
| 8/2/2024 | CROX | $247K | -13.9% | -17.2% | +13.0% |
| 3/14/2024 | CROX | $250K | +25.9% | +1.4% | +8.6% |
| 3/11/2024 | GROV | $50K | -18.2% | -28.9% | +6.9% |
| 2/2/2024 | WOLF | $260K | pending | pending | — |
| 6/9/2023 | GROV | $104K | +62.0% | +1.7% | +7.1% |
| 5/23/2023 | GROV | $100K | +22.6% | -14.3% | +9.5% |
| 4/28/2023 | WOLF | $502K | pending | pending | — |
| 3/20/2023 | GROV | $100K | +16.4% | +81.2% | +12.7% |
| 11/22/2022 | GROV | $103K | -48.9% | -34.8% | +3.5% |
| 5/23/2022 | WOLF | $505K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Grove Collaborative adds SenesTech rodent control to its e‑commerce catalog. Grove Collaborative announced that it will distribute SenesTech’s Evolve® rodent birth control products through its third‑party e‑commerce channels. The partnership targets consumers who prioritize sustainable household solutions. The addition broadens Grove’s product lineup and may attract new shoppers to its platform. The stock is currently near its $1.03 support level, which has been tested repeatedly.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Wolfspeed shares rise 6% as semiconductor sector gains. Wolfspeed jumped about 6% after investors chose the company over broader AI infrastructure plays. The move came as semiconductor stocks overall were higher on talk of a possible chip shortage. The broader sector strength appears to be supporting Wolfspeed's recent price gain.
Transaction History
| CROX | ▲ Buy | Grant | 1,252 | $0 | 6/9/2026 | View on chart |
| GROV | ▲ Buy | Option Exercise | 59,200 | — | 5/15/2026 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,923 | — | 11/17/2025 | View on chart |
| CROX | ▲ Buy | Open Market | 3,000 | $224K | 11/11/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,920 | — | 8/15/2025 | View on chart |
| CROX | ▲ Buy | Open Market | 336 | $26K | 8/8/2025 | View on chart |
| CROX | ▲ Buy | Open Market | 2,925 | $224K | 8/8/2025 | View on chart |
| CROX | ▲ Buy | Grant | 1,521 | $0 | 6/10/2025 | View on chart |
| CROX | ▲ Buy | Grant | 1,331 | $0 | 6/10/2025 | View on chart |
| GROV | ▲ Buy | Open Market | 42,735 | $50K | 5/21/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,920 | — | 5/15/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 43,692 | — | 5/15/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,920 | — | 2/15/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 726 | — | 2/15/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 5 | — | 2/14/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 12,483 | — | 2/14/2025 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,920 | — | 11/15/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,093 | — | 11/15/2024 | View on chart |
| CROX | ▲ Buy | Open Market | 2,240 | $252K | 10/30/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,920 | — | 8/15/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,093 | — | 8/15/2024 | View on chart |
| CROX | ▲ Buy | Open Market | 1,996 | $247K | 8/2/2024 | View on chart |
| CROX | ▲ Buy | Grant | 1,075 | $0 | 6/4/2024 | View on chart |
| CROX | ▲ Buy | Grant | 840 | $0 | 6/4/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,920 | — | 5/15/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 32,222 | — | 5/15/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,093 | — | 5/15/2024 | View on chart |
| CROX | ▲ Buy | Open Market | 1,972 | $250K | 3/14/2024 | View on chart |
| GROV | ▲ Buy | Open Market | 25,900 | $50K | 3/11/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,920 | — | 2/15/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,093 | — | 2/15/2024 | View on chart |
| WOLF | ▲ Buy | Open Market | 10,000 | $260K | 2/2/2024 | View on chart |
| CROX | ▲ Buy | Grant | 681 | $0 | 1/2/2024 | View on chart |
| CROX | ▲ Buy | Grant | 500 | $0 | 1/2/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 5,880 | — | 11/15/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,093 | — | 11/15/2023 | View on chart |
| WOLF | ▲ Buy | Grant | 5,383 | $0 | 10/23/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 5,880 | — | 8/15/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 3,093 | — | 8/15/2023 | View on chart |
| GROV | ▲ Buy | Open Market | 60,242 | $104K | 6/9/2023 | View on chart |
| GROV | ▲ Buy | Open Market | 207,300 | $100K | 5/23/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 15,465 | — | 5/15/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 142,156 | — | 5/15/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 29,400 | — | 5/15/2023 | View on chart |
| WOLF | ▲ Buy | Open Market | 10,566 | $502K | 4/28/2023 | View on chart |
| GROV | ▲ Buy | Open Market | 269,061 | $100K | 3/20/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 15,465 | — | 2/15/2023 | View on chart |
| GROV | ▲ Buy | Option Exercise | 29,400 | — | 2/15/2023 | View on chart |
| GROV | ▲ Buy | Open Market | 125,000 | $103K | 11/22/2022 | View on chart |
| GROV | ▲ Buy | Option Exercise | 133,071 | — | 11/15/2022 | View on chart |
| WOLF | ▲ Buy | Grant | 272 | $24K | 10/28/2022 | View on chart |
| WOLF | ▲ Buy | Grant | 2,122 | $0 | 9/1/2022 | View on chart |
| WOLF | ▲ Buy | Grant | 210 | $24K | 8/19/2022 | View on chart |
| GROV | ▼ Sell | Other | 226,203 | — | 6/16/2022 | View on chart |
| GROV | ▼ Sell | Other | 267 | — | 6/16/2022 | View on chart |
| WOLF | ▲ Buy | Open Market | 7,463 | $505K | 5/23/2022 | View on chart |
| WOLF | ▲ Buy | Grant | 274 | $24K | 5/6/2022 | View on chart |
| WOLF | ▲ Buy | Grant | 265 | $24K | 1/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Crocs (CROX) Announces Q3 2026 Earnings Call, Cites Growth
The company scheduled a conference call to discuss its third‑quarter 2026 earnings. Management highlighted accelerating international sales and expects continued growth in North America. A new partnership with BARK expands the brand into pet‑focused products, starting with a customizable dog bed. Recent commentary notes that Crocs' exposure to oil prices has diminished, improving cost stability.
Crocs (CROX) Announces Q3 2026 Earnings Call, Cites Growth. The company scheduled a conference call to discuss its third‑quarter 2026 earnings. Management highlighted accelerating international sales and expects continued growth in North America. A new partnership with BARK expands the brand into pet‑focused products, starting with a customizable dog bed. Recent commentary notes that Crocs' exposure to oil prices has diminished, improving cost stability.